Code | 1239A | ||||||||||
MA number | 27/0261/12-S | ||||||||||
Product Form: | tbl plg 28x8 mg (blis.Al/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister Al/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 15.05.2012 |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 28.02.2018 |